These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12424850)

  • 1. Molecular and biologic basis of upper gastrointestinal malignancy. Gastric carcinoma.
    el-Rifai W; Powell SM
    Surg Oncol Clin N Am; 2002 Apr; 11(2):273-91, viii. PubMed ID: 12424850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas.
    De Leng WW; Westerman AM; Weterman MA; De Rooij FW; Dekken Hv Hv; De Goeij AF; Gruber SB; Wilson JH; Offerhaus GJ; Giardiello FM; Keller JJ
    Clin Cancer Res; 2003 Aug; 9(8):3065-72. PubMed ID: 12912958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjö A; Söderkvist P
    Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.
    Lee JH; Abraham SC; Kim HS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Rashid A; Hamilton SR; Wu TT
    Am J Pathol; 2002 Aug; 161(2):611-8. PubMed ID: 12163385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase 2, p53, beta-catenin, and APC protein expression in gastric adenomatous polyps.
    Smith GV; Feakins R; Farthing MJ; Ballinger A
    Am J Clin Pathol; 2005 Mar; 123(3):415-20. PubMed ID: 15716238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability.
    Yamamoto H; Itoh F; Fukushima H; Hinoda Y; Imai K
    Int J Cancer; 1999 Aug; 84(4):400-3. PubMed ID: 10404093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
    Buecher B; Heymann MF; Blottière HM
    Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
    Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN
    Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer.
    Lee TL; Leung WK; Lau JY; Tong JH; Ng EK; Chan FK; Chung SC; Sung JJ; To KF
    Cancer Lett; 2001 Jul; 168(2):133-40. PubMed ID: 11403917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers.
    Lim S; Lee HS; Kim HS; Kim YI; Kim WH
    Histopathology; 2003 Feb; 42(2):128-36. PubMed ID: 12558744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
    Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
    J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
    Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
    Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
    Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin JP; Sipponen P; Ristimäki A
    Clin Cancer Res; 2001 Jul; 7(7):1923-31. PubMed ID: 11448905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 and gastric carcinogenesis.
    Saukkonen K; Rintahaka J; Sivula A; Buskens CJ; Van Rees BP; Rio MC; Haglund C; Van Lanschot JJ; Offerhaus GJ; Ristimaki A
    APMIS; 2003 Oct; 111(10):915-25. PubMed ID: 14616542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
    Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
    Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
    Lefebvre AM; Chen I; Desreumaux P; Najib J; Fruchart JC; Geboes K; Briggs M; Heyman R; Auwerx J
    Nat Med; 1998 Sep; 4(9):1053-7. PubMed ID: 9734399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
    Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
    Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
    J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.